UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Gut Microbiota and Immune System Relationship in Human Graft-versus-Host Disease

Mediterranean journal of hematology and infectious diseases, 2016-05, Vol.8 (1), p.e2016025-e2016025

2016

Volltextzugriff (PDF)

The Microbiota-Gut-Brain Axis: Psychoneuroimmunological Insights

Nutrients, 2023-03, Vol.15 (6), p.1496

2023

Volltextzugriff (PDF)

Inflammatory Bowel Diseases and Non-Alcoholic Fatty Liver Disease: Piecing a Complex Puzzle Together

International journal of molecular sciences, 2024-03, Vol.25 (6), p.3278

2024

Volltextzugriff (PDF)

Fibrostenosing Crohn's Disease: Pathogenetic Mechanisms and New Therapeutic Horizons

International journal of molecular sciences, 2024-06, Vol.25 (12), p.6326

2024

Volltextzugriff (PDF)

Cellular and Molecular Determinants of Biologic Drugs Resistance and Therapeutic Failure in Inflammatory Bowel Disease

International journal of molecular sciences, 2024-02, Vol.25 (5), p.2789

2024

Volltextzugriff (PDF)

Ecology and Machine Learning-Based Classification Models of Gut Microbiota and Inflammatory Markers May Evaluate the Effects of Probiotic Supplementation in Patients Recently Recovered from COVID-19

International journal of molecular sciences, 2023-04, Vol.24 (7), p.6623

2023

Volltextzugriff (PDF)

Redo endoscopic sleeve gastroplasty: technical aspects and short-term outcomes

Therapeutic advances in gastroenterology, 2020-01, Vol.13, p.1756284819896179

2020

Volltextzugriff (PDF)

Targeting the Microbiome for Disease Diagnosis and Therapy: New Frontiers for Personalized Medicine

Laterza, Lucrezia

2022

Volltextzugriff (PDF)

Body mass index influences infliximab post-infusion levels and correlates with prospective loss of response to the drug in a cohort of inflammatory bowel disease patients under maintenance therapy with Infliximab

PloS one, 2017-10, Vol.12 (10), p.e0186575-e0186575

2017

Volltextzugriff (PDF)

Role of yeasts in healthy and impaired gut microbiota: the gut mycome

Current pharmaceutical design, 2014-01, Vol.20 (28), p.4565-4569

2014

Volltextzugriff (PDF)

Multimodal dynamic ultrasound approach as predictor of response in patients with Crohn's disease treated with ustekinumab

Therapeutic advances in gastroenterology, 2024-01, Vol.17, p.17562848241259289

2024

Volltextzugriff (PDF)

Multiparametric Evaluation Predicts Different Mid-Term Outcomes in Crohn’s Disease

Digestive diseases (Basel), 2018-01, Vol.36 (3), p.184-193

2018

Volltextzugriff (PDF)

Gut Microbiota during Dietary Restrictions: New Insights in Non-Communicable Diseases

Microorganisms (Basel), 2020-08, Vol.8 (8), p.1140

2020

Volltextzugriff (PDF)

Gut and Reproductive Tract Microbiota Adaptation during Pregnancy: New Insights for Pregnancy-Related Complications and Therapy

Microorganisms (Basel), 2021-02, Vol.9 (3), p.473

2021

Volltextzugriff (PDF)

Extracellular Vesicles: Novel Potential Therapeutic Agents in Inflammatory Bowel Diseases

Cells (Basel, Switzerland), 2023-12, Vol.13 (1), p.90

2023

Volltextzugriff (PDF)

Microparticles Produced by Activated Platelets Carry a Potent and Functionally Active Angiogenic Signal in Subjects with Crohn's Disease

International journal of molecular sciences, 2018-09, Vol.19 (10), p.2921

2018

Volltextzugriff (PDF)

Navigating the Intersection: Sarcopenia and Sarcopenic Obesity in Inflammatory Bowel Disease

Biomedicines, 2024-05, Vol.12 (6), p.1218

2024

Volltextzugriff (PDF)

Nodular lymphoid hyperplasia: A marker of low-grade inflammation in irritable bowel syndrome?

World journal of gastroenterology : WJG, 2016-12, Vol.22 (46), p.10198-10209

2016

Volltextzugriff (PDF)

Bariatric procedures and microbiota: patient selection and outcome prediction

Therapeutic Advances in Gastrointestinal Endoscopy, 2021, Vol.14, p.26317745211014746-26317745211014746

2021

Volltextzugriff (PDF)

Serial Fecal Microbiota Infusions via Colonoscopy for Active Ulcerative Colitis: A Feasibility, Safety, and Translational Monocentric Italian Study

Microorganisms (Basel), 2023-10, Vol.11 (10), p.2536

2023

Volltextzugriff (PDF)

Irritable Bowel Syndrome and Nickel Allergy: What Is the Role of the Low Nickel Diet?

Journal of neurogastroenterology and motility, 2017-01, Vol.23 (1), p.101-108

2017

Volltextzugriff (PDF)

Origin of celiac disease： How old are predisposing haplotypes

World journal of gastroenterology : WJG, 2012-10, Vol.18 (37), p.5300-5304

2012

Volltextzugriff (PDF)

The Microbiome Revolution: New Insights for Personalized Medicine

Journal of personalized medicine, 2022-09, Vol.12 (9), p.1520

2022

Volltextzugriff (PDF)

Risk factors for gastric cancer: is it time to discard PPIs?

Gut, 2019-01, Vol.68 (1), p.176-177

2019

Volltextzugriff (PDF)

1 – 25 von 72

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(62)
Mit Volltextzugriff
(61)

Publikationsform

Sprache

Englisch
(72)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The Gut Microbiota and Immune System Relationship in Human Graft-versus-Host Disease

The Microbiota-Gut-Brain Axis: Psychoneuroimmunological Insights

Inflammatory Bowel Diseases and Non-Alcoholic Fatty Liver Disease: Piecing a Complex Puzzle Together

Fibrostenosing Crohn's Disease: Pathogenetic Mechanisms and New Therapeutic Horizons

Cellular and Molecular Determinants of Biologic Drugs Resistance and Therapeutic Failure in Inflammatory Bowel Disease

Ecology and Machine Learning-Based Classification Models of Gut Microbiota and Inflammatory Markers May Evaluate the Effects of Probiotic Supplementation in Patients Recently Recovered from COVID-19

Redo endoscopic sleeve gastroplasty: technical aspects and short-term outcomes

Targeting the Microbiome for Disease Diagnosis and Therapy: New Frontiers for Personalized Medicine

Body mass index influences infliximab post-infusion levels and correlates with prospective loss of response to the drug in a cohort of inflammatory bowel disease patients under maintenance therapy with Infliximab

Role of yeasts in healthy and impaired gut microbiota: the gut mycome

Multimodal dynamic ultrasound approach as predictor of response in patients with Crohn's disease treated with ustekinumab

Multiparametric Evaluation Predicts Different Mid-Term Outcomes in Crohn’s Disease

Gut Microbiota during Dietary Restrictions: New Insights in Non-Communicable Diseases

Gut and Reproductive Tract Microbiota Adaptation during Pregnancy: New Insights for Pregnancy-Related Complications and Therapy

Extracellular Vesicles: Novel Potential Therapeutic Agents in Inflammatory Bowel Diseases

Microparticles Produced by Activated Platelets Carry a Potent and Functionally Active Angiogenic Signal in Subjects with Crohn's Disease

Navigating the Intersection: Sarcopenia and Sarcopenic Obesity in Inflammatory Bowel Disease

Nodular lymphoid hyperplasia: A marker of low-grade inflammation in irritable bowel syndrome?

Bariatric procedures and microbiota: patient selection and outcome prediction

Serial Fecal Microbiota Infusions via Colonoscopy for Active Ulcerative Colitis: A Feasibility, Safety, and Translational Monocentric Italian Study

Irritable Bowel Syndrome and Nickel Allergy: What Is the Role of the Low Nickel Diet?

Impact of SARS-CoV-2 Infection on the Course of Inflammatory Bowel Disease in Patients Treated with Biological Therapeutic Agents: A Case-Control Study

Origin of celiac disease： How old are predisposing haplotypes

The Microbiome Revolution: New Insights for Personalized Medicine

Risk factors for gastric cancer: is it time to discard PPIs?

Suchergebnisse filtern